Connor, Clark & Lunn Investment Management (CC&L)’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78M Buy
+161,443
New +$42.8M 0.15% 132
2025
Q4
Sell
-10,044
Closed -$1.97M 1818
2025
Q3
$1.97M Buy
10,044
+3,244
+48% +$533K 0.01% 856
2025
Q2
$615K Buy
+6,800
New +$537K ﹤0.01% 1192

Other funds holding ALAB

Connor, Clark & Lunn Investment Management (CC&L)'s ALAB Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Astera Labs (ALAB) in Q2 2026: 161,443 shares worth $78M. The stake represents 0.15% of the portfolio and ranks #132 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in ALAB as recently as Q3 2025.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ALAB in Q2 2025 and has held it in 3 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 161,443 shares of Astera Labs worth $78M as of Q2 2026.
  • Astera Labs was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q2 2026.
  • Astera Labs made up 0.15% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #132 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Astera Labs in Q2 2025 and has held it in 3 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.